A detailed history of Concourse Financial Group Securities, Inc. transactions in Embecta Corp. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 33 shares of EMBC stock, worth $669. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33
Previous 33 -0.0%
Holding current value
$669
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$12.87 - $19.09 $25 - $38
-2 Reduced 5.71%
33 $0
Q1 2023

May 15, 2023

SELL
$23.07 - $32.77 $8,166 - $11,600
-354 Reduced 91.0%
35 $0
Q4 2022

Jan 30, 2023

SELL
$25.29 - $35.48 $910 - $1,277
-36 Reduced 8.47%
389 $0
Q3 2022

Nov 15, 2022

SELL
$24.0 - $33.42 $768 - $1,069
-32 Reduced 7.0%
425 $12,000
Q2 2022

Aug 09, 2022

BUY
$24.78 - $33.36 $11,324 - $15,245
457 New
457 $12,000
Q1 2022

May 09, 2022

BUY
$33.33 - $47.0 $0 - $0
0 New
0 $0

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.